Inogen (Nasdaq:INGN) today announced that it named Mike Sergesketter as interim CFO after Kristin Caltrider stepped down.
Caltrider stepped down from the position, citing personal reasons. Her decision has no relation to any disagreements with the company or its management, operations, policies or practices. The company, which provides respiratory products for the homecare setting, enlisted a leading executive search firm to begin the process of finding a permanent replacement.
Sergesketter takes on the interim post, having previously assumed that role between December 2021 and March 2022. Before that, he served as CFO at Kimball Electronics.
“I would like to thank Kristin for her contributions to Inogen and share my optimism for the future of the company as we continue our strategic evolution to become a more prominent player in respiratory care,” said Nabil Shabshab, Inogen president and CEO. “Mike has brought value to Inogen as an accomplished CFO and partner to me, and I am pleased to welcome him back to the company. His decades of experience across finance, M&A, and strategic manufacturing, as well as his track record of being a partner and advisor cross-functionally are strong assets as we continue to execute against our 2023 plans and prepare for 2024.”
Sergesketter comes with more than 40 years of finance experience in the manufacturing services industry. During his time at Kimball Electronics and its predecessors, he held responsibilities for a number of critical finance functions. Those included SEC reporting, treasury, investor relations, tax, financial planning and analysis and internal audit. He also played a role in various M&A transactions.
Following the executive change, Inogen reaffirmed its 2023 financial guidance. It projects revenues between $315 million and $320 million.
